{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:10Z","timestamp":1790152150731,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2412,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/mt.2009.305","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T15:09:58Z","timestamp":1264518598000},"page":"502-510","source":"Crossref","is-referenced-by-count":71,"title":["Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Cathryn S","family":"Mah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin J","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry S","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara R","family":"DeRuisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry O","family":"Cresawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Fraites Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Campbell-Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2009.305_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid \u03b1-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1038\/mt.2009.305_bib2","first-page":"1139","article-title":"An electron microscopic and biochemical study of type II glycogenosis","volume":"13","author":"Baudhuin","year":"1964","journal-title":"Lab Invest"},{"key":"10.1038\/mt.2009.305_bib3","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","article-title":"Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein","volume":"93","author":"Kessler","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.305_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00415-006-0434-2","article-title":"Fatigue: an important feature of late-onset Pompe disease","volume":"254","author":"Hagemans","year":"2007","journal-title":"J Neurol"},{"key":"10.1038\/mt.2009.305_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid \u03b1-glucosidase deficiency (glycogenosis type II, Pompe disease","volume":"2","author":"Raben","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1038\/mt.2009.305_bib6","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/mus.880181414","article-title":"Glycogenosis type II (acid maltase deficiency)","volume":"3","author":"Reuser","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1038\/mt.2009.305_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid \u03b1-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1038\/mt.2009.305_bib8","first-page":"1101","article-title":"\u03b1-Glucosidase (CHO) (Genzyme)","volume":"5","author":"Lachmann","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1038\/mt.2009.305_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/hum.2005.16.68","article-title":"Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid \u03b1-glucosidase in a model of glycogen storage disease type II","volume":"16","author":"Cresawn","year":"2005","journal-title":"Hum Gene Ther"},{"issue":"5\u00a0Pt 1","key":"10.1038\/mt.2009.305_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","article-title":"Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors","volume":"5","author":"Fraites","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ymthe.2004.01.006","article-title":"A new method for recombinant adeno-associated virus vector delivery to murine diaphragm","volume":"9","author":"Mah","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.gt.3302550","article-title":"Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors","volume":"12","author":"Mah","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.305_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib14","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1242\/dev.01169","article-title":"Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease","volume":"131","author":"Rucker","year":"2004","journal-title":"Development"},{"key":"10.1038\/mt.2009.305_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","article-title":"Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter","volume":"11","author":"Sun","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/mt.2008.133","article-title":"Correction of multiple striated muscles in murine pompe disease through adeno-associated virus-mediated gene therapy","volume":"16","author":"Sun","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2008.010","article-title":"Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid \u03b1-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice","volume":"19","author":"Ziegler","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.305_bib18","first-page":"1","article-title":"Biology of adeno-associated virus","volume":"218","author":"Berns","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1038\/mt.2009.305_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1566523054065057","article-title":"New recombinant serotypes of AAV vectors","volume":"5","author":"Gao","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2009.305_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/JVI.72.1.309-319.1998","article-title":"Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2","volume":"72","author":"Rutledge","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2009.305_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"},{"key":"10.1038\/mt.2009.305_bib22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/mthe.2001.0449","article-title":"Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors","volume":"4","author":"Chao","year":"2001","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib24","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","article-title":"Gene therapy vectors based on adeno-associated virus type 1","volume":"73","author":"Xiao","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2009.305_bib25","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.305_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1165\/ajrcmb.13.5.7576685","article-title":"Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm","volume":"13","author":"Petrof","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6 Pt 1","key":"10.1038\/mt.2009.305_bib27","first-page":"L1023","article-title":"Phenotypic and immunologic factors affecting plasmid-mediated in vivo gene transfer to rat diaphragm","volume":"270","author":"Petrof","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1038\/mt.2009.305_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.gt.3300600","article-title":"Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice","volume":"5","author":"Yang","year":"1998","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.305_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/mt.2009.305_bib30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/gt.2009.71","article-title":"Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders","volume":"16","author":"Koppanati","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.305_bib31","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1128\/JVI.00895-06","article-title":"\u03b12,3 and \u03b12,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6","volume":"80","author":"Wu","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2009.305_bib32","doi-asserted-by":"crossref","first-page":"29684","DOI":"10.1074\/jbc.M604099200","article-title":"Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia","volume":"281","author":"Yan","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.305_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mthe.2002.0563","article-title":"Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction","volume":"5","author":"Ding","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib34","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/hmg\/11.14.1637","article-title":"Muscle as a putative producer of acid \u03b1-glucosidase for glycogenosis type II gene therapy","volume":"11","author":"Martin-Touaux","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2009.305_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11910-007-0024-4","article-title":"Acid \u03b1-glucosidase deficiency (Pompe disease)","volume":"7","author":"Fukuda","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1038\/mt.2009.305_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/mt.2009.25","article-title":"Induction of immune tolerance to FIX following muscular AAV gene transfer is AAV-dose\/FIX-level dependent","volume":"17","author":"Kelly","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib37","doi-asserted-by":"crossref","first-page":"11899","DOI":"10.1128\/JVI.00890-06","article-title":"Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells","volume":"80","author":"Xin","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2009.305_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.gt.3303037","article-title":"Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re administration in mice","volume":"15","author":"Petry","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.305_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000306309.85301.e2","article-title":"Lack of toxicity of \u03b1-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D","volume":"71","author":"Rodino-Klapac","year":"2008","journal-title":"Neurology"},{"key":"10.1038\/mt.2009.305_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/gt.2008.70","article-title":"A canine minidystrophin is functional and therapeutic in mdx mice","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.305_bib41","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.305_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","article-title":"Nervous system in Pompe's disease. Ultrastructure and biochemistry","volume":"30","author":"Gambetti","year":"1971","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2009.305_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/hum.2007.093","article-title":"Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons","volume":"19","author":"Foust","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.305_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.mt.6300367","article-title":"Efficient retrograde neuronal transduction utilizing self-complementary AAV1","volume":"16","author":"Hollis","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.305_bib45","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"10.1038\/mt.2009.305_bib46","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1038\/mt.2009.305_bib47","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid \u03b1-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2009.305_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1056-8719(02)00191-0","article-title":"Pulmonary function assessment by whole-body plethysmography in restrained versus unrestrained mice","volume":"47","author":"DeLorme","year":"2002","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1038\/mt.2009.305_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1542\/peds.16.1.81","article-title":"A barometric method for measuring ventilation in newborn infants","volume":"16","author":"Drorbaugh","year":"1955","journal-title":"Pediatrics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T19:33:16Z","timestamp":1685388796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616322985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1525001616322985"],"URL":"https:\/\/doi.org\/10.1038\/mt.2009.305","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}